Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mega (1.1tn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (614.4bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (443.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (370.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (334.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (313.6bn) 0 No activity — —
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (298.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (247.3bn) 0 No activity — 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (226.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (221.7bn) -1–5 -$1M–$10M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Mega (201.4bn) 0 No activity — 0–15%
Healthcare Services Large (188.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (171.6bn) 0 No activity — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (144.8bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (143.8bn) 0 No activity — 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (140.4bn) 0 No activity — 0–15%
Healthcare Services Large (137.3bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (132.4bn) 0 No activity — 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (127.2bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (119.9bn) 0 No activity — 0–15%
Healthcare Services Large (111.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (107.4bn) 0 No activity — 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (104.9bn) 0 No activity — 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (101.1bn) 11–20 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (96.7bn) 0 No activity — 15–50%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 No activity — 0–15%
Healthcare Services Large (81.9bn) 0 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (80.8bn) 0 No activity — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 No activity — —
Healthcare Services Large (72.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (69.5bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (65.3bn) 0 No activity — 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 No activity — 0–15%
US Cencora Inc (COR)
Healthcare Services Large (61.7bn) 1–5 $1M–$10M 0–15% 0–15%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (61.3bn) -1–5 -$1M–$10M -0–15% 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (55.1bn) 1–5 $1M–$10M 0–15% —
Healthcare Services Large (53.0bn) -1–5 -$1M–$10M -0–15% 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (49.4bn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Large (48.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (46.8bn) -1–5 -< $100K -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (46.4bn) -1–5 -$100M+ -15–50% 0–15%
Pharmaceuticals & Medical Research Large (45.4bn) 0 No activity — 0–15%
US Humana Inc (HUM)
Healthcare Services Large (45.0bn) 0 No activity — 0–15%
Healthcare Services Large (44.7bn) 0 No activity — 50%+
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 No activity — 0–15%
Healthcare Services Large (43.1bn) 0 No activity — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (41.0bn) 0 No activity — 0–15%
US Waters Corp (WAT)
Healthcare Services Large (40.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (40.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (39.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (39.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (38.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (38.3bn) 0 No activity — 0–15%
US DexCom Inc (DXCM)
Healthcare Services Large (34.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (33.4bn) 0 No activity — 0–15%
Healthcare Services Large (32.9bn) 1–5 $100K–$1M 0–15% 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (32.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 No activity — 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (31.9bn) 0 No activity — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (31.7bn) -1–5 -$10M–$100M -0–15% 0–15%
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 0 No activity — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (30.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (29.1bn) 1–5 $10M–$100M 50%+ 15–50%
US Illumina Inc (ILMN)
Healthcare Services Large (28.4bn) -1–5 -$100M+ -0–15% 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 No activity — 0–15%
Healthcare Services Large (26.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (26.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (26.2bn) -6–10 -$100M+ -0–15% 15–50%
Healthcare Services Large (26.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (26.0bn) 0 No activity — 0–15%
Healthcare Services Large (24.7bn) 0 No activity — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (24.5bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (23.9bn) -1–5 -$1M–$10M -0–15% 50%+
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 No activity — 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.3bn) 0 No activity — 50%+
Healthcare Services Large (23.2bn) 1–5 $100K–$1M 0–15% 15–50%
IE STERIS plc (STE)
Healthcare Services Large (23.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (22.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (21.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (21.7bn) -11–20 -$10M–$100M -0–15% 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (21.5bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (21.3bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (20.9bn) 0 -< $100K -0–15% 15–50%
Pharmaceuticals & Medical Research Large (20.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (19.4bn) 0 No activity — 50%+
Healthcare Services Large (18.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (18.2bn) 0 No activity — 0–15%
Healthcare Services Large (17.9bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (17.7bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Large (17.5bn) 1–5 $100K–$1M 0–15% 15–50%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 No activity — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (16.6bn) -6–10 -$10M–$100M -0–15% 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (16.5bn) 0 No activity — —
Pharmaceuticals & Medical Research Large (16.3bn) -1–5 -$10M–$100M -0–15% 15–50%
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (15.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (15.6bn) 0 No activity — 0–15%